Bristol-Myers Squibb (BMY) just unveiled an update.
Bristol Myers Squibb has made a significant announcement available on their website, detailing their financial and operational strategies along with the second quarter financial results of 2024 during a conference call and webcast. They have provided non-GAAP financial measures, with reconciliations to the standard GAAP metrics, emphasizing the importance of understanding these alongside their Earnings Press Release. However, they caution that the presentation may be removed from the website at any time and that the information, while informative, should not be considered legally filed or liable under securities laws.
Find detailed analytics on BMY stock on TipRanks’ Stock Analysis page.
